Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24299966)

1.

Primary endocrine therapy as an approach for patients with localized breast cancer deemed not to be surgical candidates.

Hilton J, Arnaout A, Clemons M.

Curr Opin Support Palliat Care. 2014 Mar;8(1):53-8. doi: 10.1097/SPC.0000000000000026. Review.

PMID:
24299966
2.

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

Freedman OC, Verma S, Clemons MJ.

Cancer Treat Rev. 2005 Feb;31(1):1-17. Epub 2004 Nov 18. Review.

PMID:
15707700
3.

Endocrine therapy for advanced/metastatic breast cancer.

Schiavon G, Smith IE.

Hematol Oncol Clin North Am. 2013 Aug;27(4):715-36, viii. doi: 10.1016/j.hoc.2013.05.004. Epub 2013 Jun 18. Review.

PMID:
23915741
4.
5.

Endocrine therapy for early breast cancer.

Hussain SA, Williams S, Stevens A, Rea DW.

Expert Rev Anticancer Ther. 2004 Oct;4(5):877-88. Review.

PMID:
15485321
6.

Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.

Singh Ranger G.

J Clin Pharm Ther. 2005 Aug;30(4):313-7. Review. Erratum in: J Clin Pharm Ther. 2005 Oct;30(5):496. Sing Ranger, G [corrected to Singh Ranger, G].

PMID:
15985044
7.

[Neoadjuvant endocrine therapy for locally advanced breast cancer].

Viola G, Sergi D, Conti F, Lopez M.

Clin Ter. 2007 Sep-Oct;158(5):441-52. Review. Italian.

PMID:
18062352
8.

Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.

Michaud LB, Buzdar AU.

Drugs Aging. 2000 Apr;16(4):261-71. Review.

PMID:
10874521
9.

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

Rasmussen BB, Regan MM, Lykkesfeldt AE, Dell'Orto P, Del Curto B, Henriksen KL, Mastropasqua MG, Price KN, Méry E, Lacroix-Triki M, Braye S, Altermatt HJ, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Gusterson BA, Thürlimann B, Coates AS, Viale G; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Lancet Oncol. 2008 Jan;9(1):23-8. Epub 2007 Dec 20.

PMID:
18083065
10.
11.

Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A.

J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309. doi: 10.1093/jnci/djr242. Epub 2011 Jul 9. Review.

12.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS; ATAC Trialists' Group.

Lancet. 2005 Jan 1-7;365(9453):60-2.

PMID:
15639680
13.

Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS.

J Oncol Pract. 2012 Nov;8(6):e149-57. doi: 10.1200/JOP.2012.000543. Epub 2012 Jul 17.

15.

Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.

Jankowitz RC, McGuire KP, Davidson NE.

Breast. 2013 Aug;22 Suppl 2:S165-70. doi: 10.1016/j.breast.2013.07.032. Review.

PMID:
24074781
16.

Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.

Gradishar WJ.

Oncology. 2005;69(1):1-9. Epub 2005 Jul 28. Review.

PMID:
16088229
17.

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

Carlson RW, Henderson IC.

Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. Review.

PMID:
14535531
18.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
19.

Neoadjuvant endocrine therapy in breast cancer.

Abrial C, Mouret-Reynier MA, Curé H, Feillel V, Leheurteur M, Lemery S, Le Bouëdec G, Durando X, Dauplat J, Chollet P.

Breast. 2006 Feb;15(1):9-19. Epub 2005 Oct 17. Review.

PMID:
16230013
20.

Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.

Nabholtz JM.

Am J Hosp Palliat Care. 2004 Nov-Dec;21(6):457-65. Review.

PMID:
15612238
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk